Androgen receptors in prostate cancer

Journal of Endocrinology

Volumn 151, Issue 1, 1996, Pages 1-11

  Bentel, J M ^a   Tilley, W D ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TUMOR GROWTH;

HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUTATION; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 0029802619     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1510001     Document Type: Review

References (91)

1. Balk SP, Shuster TD, Fenton M-A, Taplin M-E & Bubley GJ 1996 Functional analysis of mutant androgen receptor from androgen independent prostate cancer. Keystone Symposia, Breast and Prostate Cancer: Basic Mechanisms. Taos, NM, USA (Abstract 200).
2. Barrack ER & Tindall DJ 1987 A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer. Progress in Clinical and Biological Research 239 155-187.
3. Berrevoets CA, Veldscholte J & Mulder E 1993 Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors, Journal of Steroid Biochemistry and Molecular Biology 46 731-736.
4. Bissada NK & Kaczmarek AT 1995 Complete remission of hormone refractory adenocarcinoma of the prostate in response to withdrawal of diethylstilbestrol. Journal of Urology 153 1944-1945.
5. Brinkmann AO & Trapman J 1995 Mutant androgen receptors in endocrine-related cancer. Endocrine-Related Cancer 2 203-214.
6. Brinkmann AO, Faber PW, van Rooij HCJ, Kuiper GGJM, Ris C, Klaasen P, van der Korput JAGM, Voorhorst MM, van Laar JH, Mulder E & Trapman J 1989 The human androgen receptor: domain structure, genomic organisation and regulation of expression. Journal of Steroid Biochemistry and Molecular Biology 34 307-310.
7. Brolin J & Ekman P 1991 Microassays for androgen and progesterone receptor quantitation as compared with standard saturation analyses in human prostatic tissues. Urological Research 19 333-336.
8. Brolin J, Andersson L & Ekman P 1991 Steroid receptor profile and receptor stability in subfractions of human prostatic tissues. Critical aspects on microassays. Urological Research 19 327-332.
9. Brolin J, Skoog L & Ekman P 1992 Immunohistochemistry and biochemistry in detection of androgen, progesterone, and oestrogen receptors in benign and malignant human prostatic tissue. Prostate 20 281-295.
10. Castagnaro M, Yandell DW, Dockhorn-Dworhiczak B, Wolfe HJ & Proemba C 1993 Human androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer. Verhandlungen der Deutschen Gesellschaft fur Pathologie 77 119-123.
11. Chamberlain NL, Driver ED & Miesfield RL 1994 The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Research 22 3181-3186.
12. Chang C, Kokontis J & Liao S 1988 Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240 324-326.
13. Chang C, Chodak G, Sarac E, Takeda H & Liao S 1989 Prostate androgen receptor: Immunohistological localisation and mRNA characterisation. Journal of Steroid Biochemistry 34 311-313.
14. Chodak GW, Kranc DM, Puy LA, Takeda H, Johnson K & Chang C 1992 Nuclear localisation of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate. Journal of Urology 147 798-803.
15. Coetzee GA & Ross RK 1994 Prostate cancer and the androgen receptor. Journal of the National Cancer Institute 86 872-873.
16. Cohen RJ, Glezerson G, Haffeejee Z & Afrika D 1990 Histologic and immunohistologic factors affecting prognosis. British Journal of Urology 66 405-410.
17. Culig Z, Hobisch A, Cronauer MV, Cato ACB, Hittmair A, Radmayr C, Eberle J, Bartsch G & Klocker H 1993 Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Molecular Endocrinology 7 1541-1550.
18. Dawson NA & McLeod DG 1995 Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome. Journal of Urology 153 1946-1947.
19. Demura T, Kuzumaki N, Oda A, Fujita H, Taniguchi N, Asano Y, Takayama N, Nonomura K & Koyanagi T 1988 Establishment of a monoclonal antibody to human androgen receptor and its clinical application for prostatic cancers. American Journal of Clinical Oncology 1 (Suppl 2) S23-S26.
20. Demura T, Kuzumaki N, Oda A, Fujita H, Ishibashi T & Koyanagi T 1989 Establishment and characterisation of monoclonal antibody against androgen receptor. Journal of Steroid Biochemistry 33 845-851.
21. Edwards A, Hammond HA, Jin L, Caskey CT & Chakraborty R 1992 Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12 241-253.
22. Ekman P & Brolin J 1991 Steroid receptor profile in human prostate cancer metastases as compared with primary prostatic carcinoma. Prostate 18 147-153.
23. Ekman P, Snochowski M, Zetterberg A, Hogherg B & Gustafsson JA 1979 Steroid receptors in human prostatic carcinoma and response to endocrine therapy. Cancer 44 1173-1181.
24. Elo JP, Kvist L, Leinonen K, Isomaa V, Henttu P, Lukkarinen O & Vihko P 1996 Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by oestradiol. Journal of Clinical Endocrinology and Metabolism 80 3494-3500.
25. Faber PW, van Rooij HCJ, van der Korput HAGM, Baarends WM, Brinkman AO, Grootegoed JA & Trapman J 1991 Characterisation of the human androgen receptor transcriptíon unit. Journal of Biological Chemistry 266 10743-10749.
26. Gaddipatti JP, McLeod DG, Heidenberg HB, Sesterhenn IA, Finger MJ, Moul JW & Srivastava S 1994 Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Research 54 2861-2864.
27. Gast A, Neuschmid-Kaspar F, Klocker H & Cato AC 1995 A single amino acid exchange abolishes dimerisation of the androgen receptor and causes Reifenstein syndrome. Molecular and Cellular Endocrinology 111 93-98.
28. Ghanadian R, Auf G, Williams G, Davis A & Richards B 1981 Predictíng the response of prostatic carcinoma to endocrine therapy. Lancet 2 1418.
29. Guileyardo JM, Johnson WD, Welsh RA, Akazaki K & Correa P 1980 Prevalence of prostate carcinoma in two US populations. Journal of the National Cancer Institute 65 311-316.
30. Halpert B, Sheehan EE, Schmalhorst WR & Scott R 1963 Carcinoma of the prostate: a survey of 5000 autopsies. Cancer (Philadelphia) 16 737-742.
31. Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H & Hittmair A 1995 Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Research 55 3068-3072.
32. Huggins C & Hodges CV 1941 Studies on prostatic cancer: 1 The effect of castration, of oestrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research 1 293-297.
33. Husmann DA, Wilson CM, McPhaul MJ, Tilley WD & Wilson JD 1990 Antipeptide antibodies to two distinct regions of the androgen receptor localise the receptor protein to the nuclei of target cells in the rat and human prostate. Endocrinology 126 2359-2368.
34. Jasper WS, Abou-Issa H, Gogate SA & Snider GB 1987 Steroid hormone receptors and endocrine response of prostatic carcinoma. Cancer Detection and Prevention 10 393-399.
35. Jaussi R, Watson G & Paigen K 1992 Modulation of androgen-responsive gene expression by oestrogen. Molecular and Cellular Endocrinology 86 187-192.
36. Jenster G, van der Korput HAGM, Trapman J & Brinkmann AO 1995 Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. Journal of Biological Chemistry 270 7341-7346.
37. Kadmon D, Thompson T, Lynch G & Scardino P 1991 Elevated plasma chromogranin-A concentrations in prostatic carcinoma. Journal of Urology 146 358-361.
38. Kelly WK & Scher HI 1993 Prostate specific antigen decline after antiandrogen withdrawal: the flutamide withdrawal syndrome. Journal of Urology 149 607-609.
39. Kemppainen JA, Lane MV, Sar M & Wilson EM 1992 Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Journal of Biological Chemistry 267 968-974.
40. Kleinerman DI, Troncoso P, Pisters LL, Sleddens HMEB, Navone NM, Ordonez NG, van der Kwast TH, Schroeder FH, Brinkmann AO, Logothetis CJ, Hseih J-T, von Eschenbach AC & Trapman J 1994 Evaluation of androgen receptor expression and structure in bone metastases of prostate carcinoma. AACR Special Conference: Basic and Clinical Aspects of Prostate Cancer, Palm Springs, CA, USA Abstract A-22.
41. Klocker H, Culig Z, Hobisch A, Cato ACB & Bartsch B 1994 Androgen receptor alterations in prostatic carcinoma. Prostate 25 266-273.
42. Kuiper GGJM & Brinkmann AO 1995 Phosphotryptic peptide analysis of the human androgen receptor: detection of a hormone-induced phosphopeptide. Biochemistry 34 1851-1857.
43. Kuiper GGJM, de Ruiter PE, Grootegoed JA & Bnnkmann AO 1991 Synthesis and post-translational modification of the androgen receptor in LNCaP cells. Molecular and Cellular Endocrinology 80 65-73.
44. Kuiper GGJM, de Kuiter PE, Trapman J, Boersma WJA, Grootegoed JA & Brinkmann AO 1993 Localisation and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptor. Biochemical Journal 291 95-101.
45. van der Kwast TH, Schalken J, Ruizeveld de Winter JA, van Vroonhoven CCJ, Mulder E, Boersma W & Trapman J 1991 Androgen receptors in endocrine-therapy-resistant human prostate cancer. International Journal of Cancer 48 189-193.
46. van Laat JH, Berrevoets CA, Trapman J, Zegers ND & Brinkmann AO 1991 Hormone-dependent androgen receptor phosphorylation is accompanied by receptor transformation in human lymph node carcinoma of the prostate cells. Journal of Biological Chemistry 266 3734-3738.
47. La Spada AR, Wilson EM, Lubahn DB, Harding AE & Fischbeck KH 1991 Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352 77-79.
48. Lobaccarro J-M, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Heron J-F, Pujol H & Sultan C 1993 Male breast cancer and the androgen receptor gene. Human Molecular Genetics 2 109-110.
49. Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS & Wilson EM 1988 Cloning of human androgen receptor complementary DNA and localisation to the X chromosome. Science 240 327-330.
50. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE & Wilson JD 1993 Genetic basis of endocrine disease. 4 The spectrum of mutations in the androgen receptor gene that causes androgen resistance. Journal of Clinical Endocrinology and Metabolism 76 17-23.
51. Masai M, Sumiya H, Akimoto S, Yatani R, Chang C, Liao S & Shimazaki J 1990 Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates. Prostate 17 293-300.
52. Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G & Pinsky L 1993 Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genetics 5 184-188.
53. Nakada SY, di Sant'Agnese PA, Moynes RA, Hiipakka RA, Liao S, Cockett ATK & Abrahamsson P-A 1993 The androgen receptor status of neuroendocrine cells in human benign and malignant prostate tissue. Cancer Research 53 1967-1970.
54. Newmark JR, Hardy DO, Tonb DC, Carter BS, Epstein JI, Isaacs WB, Brown TR & Barrack ER 1992 Androgen receptor gene mutations in human prostate cancer. Proceedings of the National Academy of Sciences of the USA 89 6319-6323.
55. O'Malley B 1990 The steroid receptor superfamily: more excitement predicted for the future. Molecular Endocrinology 4 363-369.
56. Pertschuk LP, Schaeffer H, Feldman JG, Macchia RJ, Kim Y-D, Eisenberg K, Braithwaite LV, Axiotis CA, Prins G & Greene GL 1995 Immunostaining for prostate cancer androgen receptor in paraffin identifies a subset of men with poor prognosis. Laboratory Investigation 73 302-305.
57. Quarmby VE, Beckman WC Jr, Cooke DB, Lubahn DB, Joseph DR, Wilson EM & French FS 1990 Expression and localisation of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma. Cancer Research 50 735-739.
58. Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM & French FS 1995 Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrine Reviews 16 271-321.
59. Ross R, Bernstein L, Judd H, Hanisch R, Pike M & Henderson B 1986 Serum testosterone levels in young black and white men. Journal of the National Cancer Institute 76 45-48.
60. ROSS RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC & Henderson BE 1992 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339 887-889.
61. Ruizeveld de Winter JA, Trapman J, Brinkmann AO, Boersma WJA, Mulder E, Schroeder FH, Claasen E & van der Kwast TH 1990 Androgen receptor heterogeneity in human prostatic carcinomas visualised by immunohistochemistry. Journal of Pathology 161 329-332.
62. Ruizeveld de Winter JA, Janssen PJA, Sleddens HMEB, Verleun-Mooijman MCT, Trapman J, Brinkmann AO, Santerse AB, Schroder FH & van der Kwast TH 1994 Androgen receptor status in localised and locally progressive hormone refractory human prostate cancer. American Journal of Pathology 144 735-746.
63. Sadi MV & Barrack ER 1993 Image analysis of androgen receptor immunostainnig in metastatic prostate cancer. Cancer 71 2574-2580.
64. Sadi MV, Walsh PC & Barrack ER 1991 Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer 67 3057-3064.
65. di Sant'Agnese PA & Cockett 1994 The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research. Journal of Urology 152 1927-1931.
66. Sar M, Lubahn D, French FS & Wilson EM 1990 Immunohistochemical localisation of the androgen receptor in rat and human tissues. Endocrinology 127 3180-3186.
67. Seher HI & Kelly WK 1993 Flutamide withdrawal syndrome: its impact on clinical trials in hormone-retractory prostate cancer. Journal of Clinical Oncology 11 1566-1572.
68. 24 18) in the androgen receptor gene in human prostate cancer. Biochemical and Biophysical Research Communication 198 74-80.
69. Shanef Y, Wilson EM, Hall SH, Hamil KG, Tan J-A, French FS, Mohler JL, Pretlow TG, Gumerlock PH, White RD & Schalken JA 1995 Androgen receptor gene mutations associated with prostatic carcinoma. Proceedings of the 86th Annual AACR Meeting, Toronto, Canada 36 Abstract 1605.
70. Sidh SM, Young JD, Karmi SA, Powder JR & Bashirelahi N 1979 Adenocarcinoma of prostate: role of 17β-oestradiol and 5α-dihydrotestosterone binding proteins. Urology 13 597-603.
71. Small EJ & Carroll PR 1994 Prostate specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome. Urology 43 408-410
72. Stearns ME & McGarvey T 1992 Biology of disease; prostate cancer: therapeutic, diagnostic, and basic studies. Laboratory Investigation 67 540-552.
73. Stober J, Culig Z, Gast A, Hobisch A, Radmayr C, Bartsch G, Klocker H & Cato ACB 1994 Ligand specific modulation of activity of mutant androgen receptors from human prostate cancer: a model for investigating hormone-receptor interactions. AACR Special Conference: Basic and Clinical Aspects of Prostate Cancer, Palm Springs, CA, USA. Abstract A-23.
74. Suzuki H, Sato N, Watabe Y, Masai M, Seino S & Shimazaki J 1993 Androgen receptor gene mutations in human prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 46 759-765.
75. Takahashi H, Furusato M, Allsbrook WC Jr, Nishii H, Wakui S, Barrett JC & Boyd J 1995 Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men. Cancer Research 55 1621-1624.
76. Takeda H, Chodak G, Mutchnik S, Nakamoto T & Chang C 1990 Immunohistochemical localisation of androgen receptors with mono- and polyclonal antibodies to androgen receptor. Journal of Endocrínology 126 17-25.
77. Taplin M-E, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN & Balk SP 1995 Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. New England Journal of Medicine 332 1393-1398.
78. Tilley WD, Marcelli M, Wilson JD & McPhaul MJ 1989 Characterisation and expression of a cDNA encoding the human androgen receptor. Proceedings of the National Academy of Sciences of the USA 86 327-331.
79. Tilley WD, Wilson CM, Marcelli M & McPhaul MJ 1990 Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Research 50 5382-5386.
80. Tilley WD, Lim-Tio SS, Horsfall DJ, Aspinall JO, Marshall VR & Skinner JM 1994 Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by colour video image analysis. Cancer Research 54 4096-4102.
81. Tilley WD, Buchanan G, Hickey TE & Bentel JM 1996 Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clinical Cancer Research 2 277-285.
82. Trachtenberg J & Walsh PC 1982 Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer. Journal of Urology 127 466-471.
83. Trapman J, Klaasen P, Kuiper GGJM, van der Korput JAGM, Faber PW, van Rooij HCJ, Geurts van Kessel A, Voorhorst MM, Mulder E &. Brinkman AO 1988 Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochemical and Biophysical Research Communications 153 241-248.
84. Truss M & Beato M 1993 Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrine Review 14 459-479.
85. Veldscholte J, Ris-Stalpers C, Kuiper GGJM, Jenster G, Berrevoets C, Claasen E, van Rooij HCJ, Trapman J, Brinkmann AO & Mulder E 1990 A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochemical and Biophysical Research Communication 173 534-540.
86. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J & Kallioniemi O-P 1995 In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genetics 9 401-406.
87. Wilson CM & McPhaul MJ 1994 A and B forms of the androgen receptor are present in human genital skin fibroblasts. Proceeding of the National Academy of Sciences of the USA 91 1234-1238.
88. Wingo PA, Tong T & Bolden S 1995 Cancer statistics 1995. CA A Cancer Journal for Clinicians 45 8-30.
89. Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BAJ & Stratton MR 1992 A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Gentics 2 132-134.
90. Yatani R, Shiraishi T, Nakakuki K, Kusano I, Takanari H, Hayashi T & Stemmerman GN 1988 Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 and 1982-1986. Journal of the National Cancer Institute 80 683-687.
91. Zoppi S, Wilson CM, Harbison MD, Griffin JE, Wilson JD, McPhaul MJ & Marcelli M 1993 Complete testicular feminisation caused by an amino-terminal truncation of the androgen receptor with downstream initiation. Journal of Clinical Investigation 91 1105-1112.